Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 216 entries
View as:

A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia

Phase: N/A Priority: Normal
NCT ID: NCT02044276 Org: User:
Start: 03/31/14 End: 04/24/18 Due: 04/24/19

Safety Study of Albuterol Spiromax® in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01698320 Org: User:
Start: 10/31/12 End: 12/31/13 Due: 12/31/14

A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03052725 Org: User:
Start: 03/10/17 End: 02/22/18 Due: 02/22/19

To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01785433 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02621931 Org: User:
Start: 03/22/16 End: 04/11/17 Due: 04/11/18

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT02126839 Org: User:
Start: 05/31/14 End: 02/28/15 Due: 02/28/16

A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)

Phase: N/A Priority: Normal
NCT ID: NCT01056159 Org: User:
Start: 01/31/10 End: 06/30/10 Due: 06/30/11

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01844401 Org: User:
Start: 04/30/13 End: 10/31/13 Due: 10/31/14

A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02203474 Org: User:
Start: 08/31/14 End: 08/31/14 Due: 08/31/15

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Phase: N/A Priority: Normal
NCT ID: NCT02980133 Org: User:
Start: 12/28/16 End: 04/13/19 Due: 04/13/20

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00336557 Org: User:
Start: 07/31/06 End: 07/31/09 Due: 07/31/10

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02175771 Org: User:
Start: 07/31/14 End: 07/31/15 Due: 07/31/16

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Phase: N/A Priority: Normal
NCT ID: NCT01479621 Org: User:
Start: 01/31/12 End: 07/31/13 Due: 07/31/14

A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT02365636 Org: User:
Start: 02/26/15 End: 05/09/17 Due: 05/09/18

An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT02937168 Org: User:
Start: 05/08/17 End: 05/24/17 Due: 05/24/18

Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00666224 Org: User:
Start: 01/31/04 End: 06/30/10 Due: 06/30/11

Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)

Phase: N/A Priority: Normal
NCT ID: NCT01697956 Org: User:
Start: 10/31/12 End: 02/28/13 Due: 02/28/14

Safety of New Formulation of Glatiramer Acetate

Phase: N/A Priority: Normal
NCT ID: NCT00947752 Org: User:
Start: 07/31/09 End: 11/30/09 Due: 11/30/10

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02062463 Org: User:
Start: 05/28/14 End: 03/13/15 Due: 03/13/16

A Study to Test if TEV-53275 is Effective in Relieving Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04847674 Org: User:
Start: 05/04/21 End: 04/28/22 Due: 04/28/23

A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together

Phase: N/A Priority: Normal
NCT ID: NCT02085863 Org: User:
Start: 02/28/14 End: 11/30/14 Due: 11/30/15

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Phase: N/A Priority: Normal
NCT ID: NCT00854360 Org: User:
Start: 03/31/09 End: 05/31/09 Due: 05/31/10

Multicenter Trial for Adults With Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00034814 Org: User:
Start: 01/31/02 End: 01/31/06 Due: 01/31/07

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Phase: N/A Priority: Normal
NCT ID: NCT01024608 Org: User:
Start: 12/31/09 End: 02/28/10 Due: 02/28/11

A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03813238 Org: User:
Start: 08/06/19 End: 07/21/22 Due: 07/21/23